Sensome developed a revolutionary sensor technology that turns invasive medical devices into connected healthcare devices. The company’s sensing technology combines impedance-based micro-sensors with machine learning algorithms to instantly identify biological tissues upon contact with an unequaled predictive reliability. Clotild® will be a neurovascular guidewire integrating Sensome’s unique sensor technology to support clinicians during mechanical thrombectomy for acute ischemic stroke. Clotild® is currently undergoing preclinical testing and is not yet approved anywhere in the world.

Website :